Carl Icahn is a force to reckon with, having made a name and billions of dollars on questioning decisions and strategies of ...

Edward Bausch transformed the world of optics with groundbreaking inventions like the iris diaphragm shutter and advanced ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Bausch + Lomb's stable business and the recent acquisition ... and shareholders are mostly deal-makers at heart. Gain access to all of the market research and financial analytics used in the ...

The debt refinancing is expected to help the company in the impending spinoff of its eye-care company, Bausch + Lomb. This drugmaker is expected to post quarterly earnings of $1.05 per share in ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Blackstone, Advent International and TPG are among a long list of private equity firms studying bids for ...

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company. The Financial Times reported ...